Investigators sought to determine whether a relationship exists between estradiol level and bone mineral density.
Study demonstrates the impact of lifestyle factors on the inflammatory condition.
For patients undergoing total knee arthroplasty, abelacimab, a monoclonal antibody that binds to factor XI and locks it in the zymogen conformation, is effective for preventing venous thromboembolism without increasing the risk for bleeding.
While prior research indicates that cannabis use may increase the severity of certain psychiatric symptoms, its impact on suicidality is unknown. To inform this gap, investigators extracted data from the National Surveys on Drug Use and Health for the years 2008 through 2019.
Researchers aimed to assess the efficacy and safety of oral imatinib in hospitalized patients with COVID-19 who required supplemental oxygen administration.
Among active-duty service members with posterior shoulder instability requiring surgical fixation, 12.7% develop glenohumeral arthritis.
The clinical dermatologic use of tocilizumab, its mechanisms of action, and adverse events is reviewed.
This case report described the first instance of a patient with Crohn disease and relapsing polychondritis who presented with pachymeningitis.
Giving a third dose of COVID-19 vaccines to immunocompromised adults will be up for discussion during a US Centers for Disease Control and Prevention advisory panel meeting next week.
The EULAR task force developed recommendations for the implementation of self-management strategies in inflammatory arthritis.
With depressive symptoms rising after an acute COVID-19 infection, study researchers looked at whether these symptoms are a consequence of stress associated with COVID or, do they reflect more specific sequelae associated with the pathophysiology of the illness.
Study reveals that almost 90% of men have hypogonadism at the time of hospital admission for COVID-19.
Cardiovascular drugs do not affect COVID-19 outcomes.
For hospitalized patients with COVID-19, neither remdesivir nor hydroxychloroquine (HCQ) affects viral clearance.
The FDA has updated the fact sheet for the Janssen COVID-19 vaccine to include information related to an increased risk of Guillain-Barré syndrome.